Since the widespread rollout of the COVID-19 mRNA vaccines, we have seen an alarming rise in cancer diagnoses. This is even more particularly pronounced among younger individuals, who are getting diagnosed with aggressive cancers at a concerning rate.

According to Dr. Peter McCullough, writing in his Substack, the timing of these incidents is more than coincidental:

Since late 2022, independent oncologists and immunologists—such as Professor Angus Dalgleish of St. George’s, London, and Dr. Wafik El-Deiry of Brown University—have warned of a surge in immunologic dysregulation following repeated mRNA injections. Peer-reviewed analyses (Oncotarget, January 2026) describe “rapid progression or recurrence of previously indolent cancers” temporally linked to vaccination or severe COVID-19 infection. Mechanistically, both situations share key features: chronic inflammation, spike-induced mitochondrial damage, depletion of cytotoxic T cells, suppression of p53/BRCA tumor-surveillance pathways, and the infamous IgG4 class-switch phenomenon that signals immune tolerance to pathogenic antigens. In other words, the body learns not to fight back.

The evidence is mounting that the culprit in these rising rates of cancer, particularly aggressive cancers, is connected to the deployment of the mRNA vaccines in 2021:

If spike exposure promotes tolerogenic or suppressive immune states, it effectively disables the very system responsible for preventing malignant transformation. This hypothesis not only fits the timeline—post-2021 rises in aggressive cancers—but also accounts for why tumors in the young often present suddenly and advance fast enough to be called “turbo cancers.”

Despite the mounting evidence, much of the medical establishment and their handmaidens in the legacy media refuse to acknowledge even the possibility of a link between the COVID-19 vaccines and cancer. As Dr. McCullough points out:

To acknowledge this connection would be to indict an entire biomedical complex that profited from both pandemic panic and mass inoculation. Regulatory agencies explicitly waived carcinogenicity testing for the mRNA products. Their emergency authorization was based on weeks—not years—of observation. Now the same institutions fund research asking whether microplastics or late pregnancies explain the cancer wave, as though a polymer fragment in a salad poses more biological disruption than billions of cells processing synthetic mRNA and producing a modified viral toxin inside the body.

The refusal to investigate spike biology as a carcinogenic catalyst is symptomatic of a deeper pathology: institutional capture. Pharmaceutical corporations bankroll most cancer research foundations; their executives rotate through public agencies that set the research agenda. If spike-induced oncogenesis were confirmed, it would open them to liability and moral outrage far beyond anything seen with tobacco or asbestos. Hence, the cultivated ignorance.

As Cancer Changes, So Must Our Approach to Prevention

In this new reality of rising cancer rates and the increased prevalence of aggressive “turbo-cancers,” experts like Dr. McCullough are calling on Americans to consider new approaches to prevention:

Since 2021, global oncology trends have shifted significantly. Epidemiological data indicates a troubling, unexplained acceleration in cancer diagnoses, particularly among younger, likely COVID-19 vaccinated cohorts who historically presented lower risk profiles. This phenomenon has sparked intense debate regarding potential oncogenicity of genetic vaccines, Spike protein exposure, and other determinants. As the medical establishment struggles to contextualize these shifts, the necessity for proactive, non-invasive, and highly sensitive screening modalities has become a paramount concern for patients seeking to bypass institutional inertia.

The Promise of Ivermectin and Mebendazole

The off-label use of anti-parasitic drugs like Ivermectin and Mebendazole is showing great promise in the potential to fight cancer.

Indeed, Dr. McCullough and a number of his colleagues at The Wellness Company have recently authored a first-of-its-kind study of the application of Ivermectin + Mebendazole in the treatment of cancer.

In this human observational analysis, off-label use of Ivermectin + Mebendazole showed a remarkable 84% Clinical Benefit Ratio in the treatment of cancer.

These results indicate that the inexpensive and safe off-label applications of these medications could be an important breakthrough in the treatment of cancer.

The report analyzed 197 cancer patients who were prescribed ivermectin and mebendazole off label. Participants received compounded oral capsules containing 25 mg of ivermectin and 250 mg of mebendazole. After 6 months, participants reported an 84% Clinical Benefit Ratio, with 48% of participants reporting regression or no evidence of cancer, while 36% reported disease stability. Only 15.6% of participants reported disease progression.

Cancer remains one of the leading causes of death globally, with conventional treatments such as chemotherapy, radiation therapy, and targeted agents frequently limited by significant toxicity, high cost, development of resistance, and variable long-term efficacy.

The experts at The Wellness Company undertook this study because ivermectin and mebendazole have demonstrated highly promising anti-cancer activity in preclinical models. But despite compelling preclinical data and documented safe use in cancer patients, robust clinical evidence evaluating the ivermectin–mebendazole combination in oncology remains limited.

According to Dr. McCullough:

“This study reveals an exciting new potential that should expand the consideration of ivermectin and mebendazole for inclusion in the treatment of multiple cancer types. We urgently need a full-fledged scientific investigation into this class of medications and their impact on cancer treatment.”

How You Can Get Ivermectin + Mebendazole

The Wellness Company is the only company in the world to prescribe compounded Ivermectin + Mebendazole in a high-dose 90-day supply:

Ivermectin — Backed by science and honored with a Nobel Prize, Ivermectin delivers precise treatment against parasitic infections, ensuring effective care and well-being for your family with trusted precision.

Mebendazole — Trusted by healthcare professionals, Mebendazole targets and eliminates intestinal parasites with precision, ensuring your family’s health and well-being with proven efficacy and safety.

Head over to The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse — Ivermectin + Mebendazole. Simply fill out the 2-minute intake questionnaire after checkout to complete your prescription request.

What people are saying about The Wellness Company’s Ivermectin + Mebendazole:

I am grateful to have a medicine as potentially beneficial as ivermectin and mebendazole, but the most important thing for me is the faith I have in Dr. McCullough and The Wellness Company for making a safe product, in our country. I am grateful for them protecting us through the use of proven products and the peace in knowing that I’m taking something that is precisely what it states on the labels. — Jennifer W.

My daughter was diagnosed with uterine cancer and lung nodules that turned out to be cancerous. She started taking ivermectin/mebendazole 2 weeks ago. She had a PET scan last month and her lungs were littered with dime and pea sized nodules from the top to the bottom of her lungs. She had a biopsy on the 14th of April and the Physician had to SEARCH for a nodule big enough to get a sample from, and the ONE that he found was at the bottom of her left lung that he said was only a few centimeters wide…. Thank All of you Doctors on this site for giving us HOPE and HEALING!!! — Helen

Order Ivermectin and Mebendazole from The Wellness Company today!